415 related articles for article (PubMed ID: 26926637)
21. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
Kaushik N; Anang S; Ganti KP; Surjit M
DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
[TBL] [Abstract][Full Text] [Related]
22. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
[TBL] [Abstract][Full Text] [Related]
23. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
[TBL] [Abstract][Full Text] [Related]
24. Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.
Wang W; Xu L; Brandsma JH; Wang Y; Hakim MS; Zhou X; Yin Y; Fuhler GM; van der Laan LJ; van der Woude CJ; Sprengers D; Metselaar HJ; Smits R; Poot RA; Peppelenbosch MP; Pan Q
Sci Rep; 2016 May; 6():25482. PubMed ID: 27150018
[TBL] [Abstract][Full Text] [Related]
25. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
26. The IMPDH inhibitors, ribavirin and mycophenolic acid, inhibit peste des petits ruminants virus infection.
Chang QY; Guo FC; Li XR; Zhou JH; Cai X; Pan Q; Ma XX
Vet Res Commun; 2018 Dec; 42(4):309-313. PubMed ID: 30094586
[TBL] [Abstract][Full Text] [Related]
27. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
28. Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
Qu C; Xu L; Yin Y; Peppelenbosch MP; Pan Q; Wang W
Arch Virol; 2017 Oct; 162(10):2989-2996. PubMed ID: 28623406
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.
Nan Y; Ma Z; Kannan H; Stein DA; Iversen PI; Meng XJ; Zhang YJ
Antiviral Res; 2015 Aug; 120():134-9. PubMed ID: 26086884
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis E Virus Infects Neurons and Brains.
Zhou X; Huang F; Xu L; Lin Z; de Vrij FMS; Ayo-Martin AC; van der Kroeg M; Zhao M; Yin Y; Wang W; Cao W; Wang Y; Kushner SA; Marie Peron J; Alric L; de Man RA; Jacobs BC; van Eijk JJ; Aronica EMA; Sprengers D; Metselaar HJ; de Zeeuw CI; Dalton HR; Kamar N; Peppelenbosch MP; Pan Q
J Infect Dis; 2017 Apr; 215(8):1197-1206. PubMed ID: 28199701
[TBL] [Abstract][Full Text] [Related]
31. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
[TBL] [Abstract][Full Text] [Related]
32. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes.
Lanford RE; Chavez D; Guerra B; Lau JY; Hong Z; Brasky KM; Beames B
J Virol; 2001 Sep; 75(17):8074-81. PubMed ID: 11483752
[TBL] [Abstract][Full Text] [Related]
33. A rat model for hepatitis E virus.
Debing Y; Mishra N; Verbeken E; Ramaekers K; Dallmeier K; Neyts J
Dis Model Mech; 2016 Oct; 9(10):1203-1210. PubMed ID: 27483350
[TBL] [Abstract][Full Text] [Related]
34. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
35. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
36. Antiviral Candidates for Treating Hepatitis E Virus Infection.
Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
[TBL] [Abstract][Full Text] [Related]
37. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K
Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948
[TBL] [Abstract][Full Text] [Related]
38. Antiviral effects of selected IMPDH and DHODH inhibitors against foot and mouth disease virus.
Mei-Jiao G; Shi-Fang L; Yan-Yan C; Jun-Jun S; Yue-Feng S; Ting-Ting R; Yong-Guang Z; Hui-Yun C
Biomed Pharmacother; 2019 Oct; 118():109305. PubMed ID: 31545264
[TBL] [Abstract][Full Text] [Related]
39. Suppression of interferon-α signaling by hepatitis E virus.
Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
[TBL] [Abstract][Full Text] [Related]
40. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
